<h1>Nutraceutical maker's 'proof-first' claims and third-party testing pledge raise regulatory, advertising, and product liability risks</h1> A nutraceutical company showcased at a national health expo emphasized a 'proof-first' strategy, claiming all products use patented, clinically validated ingredients and pledging third-party batch testing with published results. The company cited regulatory non-compliance statistics and alleged risks from adulterated supplements, framing its approach as consumer-safety and transparency driven. Legal issues flagged include potential regulatory scrutiny by food and drug authorities, product liability exposure if claims prove misleading or unsupported, and advertising compliance risks; disclosure of test outcomes and adherence to labeling and clinical-evidence requirements will be key to mitigating enforcement and litigation risks.